Lupin estimated diclofenac sodium topical solution, 2 percent, had estimated annual sales of $509 million in the US . Lupin estimated that diclofenac sodium topical solution, 2 percent, had estimated annual sales of $509 million in the US .
The company's product, Diclofenac Sodium Topical Solution 2 percent, is the generic version of Horizon Pharma Therapeutics Pennsaid, according to a statement from the pharmaceutical company Lupin.According to IQVIA MAT October 2022 data, Lupin estimated that diclofenac sodium topical solution, 2 percent, had estimated annual sales of $509 million in the US.